American Thoracic Society, 2024
Alanyl-tRNA synthetase fragment binds to FGFR4 and induces morphological changes and downstream signaling in liver cells with functional similarities to FGF2
Gordon Research Conference: Fibroblast Growth Factors in Development and Disease, 2024
Efzofitimod Promotes Macrophages with Anti-inflammatory Profile via Neuropilin-2 Receptor
Keystone Symposia: Myeloid Cell Diversity, 2024
Demonstration of an Isoform-Specific Anti-inflammatory Role for Neuropilin-2 Through a Novel Interaction with the Chemokine Ligand 21
Keystone Symposia: Myeloid Cell Diversity, 2024
Efzofitimod, a First-in-Class NRP2-Targeting Immunomodulator, Ameliorates Rheumatoid Arthritis and Associated Lung Fibrosis in Preclinical Models
American College of Rheumatology, 2023
Exposure-Response Analyses of Efzofitimod in Patients With Pulmonary Sarcoidosis
Frontiers in Pharmacology, 2023
Therapeutic Doses of Efzofitimod Significantly Improve Multiple Pulmonary Sarcoidosis Efficacy Measures
European Respiratory Society, 2023
Efzofitimod: A Novel Therapeutic Candidate for SSc-ILD
European Respiratory Society, 2023
EFZO-FIT™: A Phase 3 Study of Efzofitimod, a Novel Immunomodulator for the Treatment of Pulmonary Sarcoidosis
World Association for Sarcoidosis and Other Granulomatous Disorders, 2023
Identification of Key Fibrotic Extracellular Targets for Alanyl- and Aspartyl-tRNA Synthetases
International Symposium of Aminoacyl-tRNA Synthetases, 2023